Back to Amundi Amundi

TXGTXG
18 quarters

Position history for AmundiAmundi's holdings in 10x Genomics Inc Class A

Amundi previously held 0 shares of TXG (10x Genomics Inc Class A), worth $0 as of 2025-Q3.

Final Value

$0

Final Shares

0

Total Value Change

-$37.6M

Total Shares Change

-191,969

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q3
Latest
Exited
0
-100.0%
$00.0%$11.34
0
2025-Q2
Decreased
204,847
-36.0%
$2.7M0.0%$11.73
0
2025-Q1
Increased
320,340
+160x
$2.6M0.0%$9.16
42
2024-Q4
Decreased
1,988
-98.0%
$31,4700.0%$14.35
0
2024-Q3
Increased
100,892
+1245x
$2M0.0%$22.67
42
2024-Q2
Decreased
81
-99.9%
$1,5240.0%$19.45
0
2024-Q1
Increased
62,125
+46.9%
$1.8M0.0%$37.53
35
2023-Q4
Increased
42,281
+21.6%
$2.1M0.0%$55.96
31
2023-Q3
Decreased
34,767
-21.1%
$1.3M0.0%$41.25
0
2023-Q2
Decreased
44,089
-39.0%
$2.5M0.0%$56.70
0
2023-Q1
Increased
72,267
+78.2%
$3.7M0.0%$52.05
41
2022-Q4
New
40,559
-
$1.7M0.0%$36.44
36
2022-Q3
Exited
0
-100.0%
$00.0%$29.93
0
2022-Q2
Decreased
26,840
-82.4%
$1.2M0.0%$46.20
0
2022-Q1
Decreased
152,534
-17.7%
$11.2M0.0%$74.74
0
2021-Q4
Decreased
185,373
-4.0%
$19.4M0.0%$150.88
0
2021-Q3
Increased
193,079
+0.6%
$28.1M0.0%$145.94
29
2021-Q2
New
191,969
-
$37.6M0.0%$201.33
40

Other major holders of TXG: BAILLIE GIFFORD & CO, ARK Investment Management LLC, FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used